Thrombosis Journal

Table 7 Clinical outcomes for major or nonmajor surgeries by renal function

From: Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study

	Major surgeries			Nonmajor surgeries
	CrCL ≤ 50 (n = 64)	CrCL > 50 (n = 189)	CrCL unknown (n = 23)	CrCL ≤ 50 (n = 134)	CrCL > 50 (n = 302)	CrCL unknown (n = 76)
All bleeding	1 (1.6)	10 (5.3)	1 (4.3)	7 (5.2)	6 (2.0)	4 (5.3)
Major bleeding^a	0	1 (0.5)	0	1 (0.7)	1 (0.3)	1 (1.3)
CRNMB	0	4 (2.1)	0	1 (0.7)	0	0
Minor bleeding	1 (1.6)	5 (2.6)	1 (4.3)	5 (3.7)	5 (1.7)	3 (3.9)
ACS	0	0	0	0	0	0
Stroke	0	0	0	1 (0.7)	0	0
TIA	0	0	0	0	0	0
SEE	0	1 (0.5)	0	0	0	0
All-cause death	0	2 (1.1)	0	0	0	0
CV death	0	0	0	0	0	0

Data are shown as n (number of events per 100 surgeries)
ACS Acute coronary syndrome, CrCL Creatinine clearance (mL/min), CRNMB Clinically relevant nonmajor bleeding, CV Cardiovascular, n Number of surgeries, SEE Systemic embolism event, TIA Transient ischaemic attack
^aInternational Society of Thrombosis and Haemostasis definition

Back to article page

ISSN: 1477-9560

Contact us

Submission enquiries: journalsubmissions@springernature.com